[1]
“Cost-Effectiveness of Length of Stay of Intravenous Aminophylline and Nebulized Salbutamol in Asthma Exacerbations”, J. Trop. Pharm. Chem, vol. 8, no. 1, pp. 35–47, Jun. 2024, doi: 10.30872/j.trop.pharm.chem.v8i1.167.